176 related articles for article (PubMed ID: 26863705)
1. Pharmacotherapy of Type 2 Diabetes Mellitus: Navigating Current and New Therapies.
Lew KN; Wick A
Medsurg Nurs; 2015; 24(6):413-9, 438. PubMed ID: 26863705
[TBL] [Abstract][Full Text] [Related]
2. Women with Type 2 Diabetes and Glycemic Control.
Gosse S
Medsurg Nurs; 2014; 23(5):317-20, 329. PubMed ID: 26292437
[TBL] [Abstract][Full Text] [Related]
3. Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus.
Blonde L
Am J Med; 2010 Mar; 123(3 Suppl):S12-8. PubMed ID: 20206727
[TBL] [Abstract][Full Text] [Related]
4. Glycemic control in type 2 diabetes mellitus.
Quevedo SF; Westrick E
Med Health R I; 1998 Nov; 81(11):345-8. PubMed ID: 15580787
[No Abstract] [Full Text] [Related]
5. Using standardized nursing languages: a case study exemplar on management of diabetes mellitus.
Fischetti N
Int J Nurs Terminol Classif; 2008; 19(4):163-6. PubMed ID: 19128335
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions in type 2 diabetes: the role of nurses.
Rodgers J
Br J Nurs; 2000 Jul 13-26; 9(13):866-70. PubMed ID: 11261060
[TBL] [Abstract][Full Text] [Related]
7. Treatment of glycemic control in diabetes in the CVOT era.
Einhorn D
J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
[No Abstract] [Full Text] [Related]
8. Management of Daily Glycemic Fluctuations in Patients With Type 2 Diabetes.
Kushner PR
J Fam Pract; 2016 Nov; 65(11 Suppl):. PubMed ID: 28087879
[TBL] [Abstract][Full Text] [Related]
9. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.
Jellinger PS; Davidson JA; Blonde L; Einhorn D; Grunberger G; Handelsman Y; Hellman R; Lebovitz H; Levy P; Roberts VL;
Endocr Pract; 2007; 13(3):260-8. PubMed ID: 17599857
[No Abstract] [Full Text] [Related]
10. [Compliance to treatment and type 2 diabetes: impact on glycemic balance].
Guillausseau PJ
Presse Med; 2003 Jan; 32(2):70. PubMed ID: 12653029
[No Abstract] [Full Text] [Related]
11. Glycemic variability: too often overlooked in type 2 diabetes?
Johnson EL
J Fam Pract; 2010 Aug; 59(8):E1-8. PubMed ID: 20714447
[TBL] [Abstract][Full Text] [Related]
12. Comparison of glycemic control of type 2 diabetes between private hospital and governmental hospital.
Al-Shaikh AA
Saudi Med J; 2006 Mar; 27(3):424-6. PubMed ID: 16532119
[No Abstract] [Full Text] [Related]
13. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus.
Eledrisi M
Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995
[No Abstract] [Full Text] [Related]
14. [Intensive glucose control in type 2 diabetes. The benefit greater than the risks?].
Rydén M; Freyschuss B
Lakartidningen; 2008 Oct 15-21; 105(42):2910-1. PubMed ID: 19025147
[No Abstract] [Full Text] [Related]
15. Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany.
Heinemann L; Deiss D; Siegmund T; Schlüter S; Naudorf M; von Sengbusch S; Lange K; Freckmann G
Exp Clin Endocrinol Diabetes; 2018 Jul; 126(7):411-428. PubMed ID: 29975980
[No Abstract] [Full Text] [Related]
16. Treatment urgency: The importance of getting people with type 2 diabetes to target promptly.
Felton AM; LaSalle J; McGill M;
Diabetes Res Clin Pract; 2016 Jul; 117():100-3. PubMed ID: 27329028
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes: treatment goals and pharmaceutical therapies. 2.
Butler RN; Rubenstein AH; Gracia AM; Zweig SC
Geriatrics; 1998 Apr; 53(4):42-8, 51. PubMed ID: 9559027
[TBL] [Abstract][Full Text] [Related]
18. Moving beyond HbA1c and plasma glucose levels to understand glycemic status in type 2 diabetes mellitus.
Vijayakumar V; Mavathur R; Aruchunan M; Nandi Krishnamurthy M
J Diabetes; 2018 Jul; 10(7):609-610. PubMed ID: 29437298
[No Abstract] [Full Text] [Related]
19. [Diagnosis and treatment goals in diabetes type].
Lilja M; Hellgren M; Jansson S
Lakartidningen; 2018 Feb; 115():. PubMed ID: 29461567
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study clarifying profiles of patients with diabetes who discontinued pharmacotherapy: reasons and consequences.
Tominaga Y; Morisky DE; Mochizuki M
BMC Endocr Disord; 2021 Jun; 21(1):117. PubMed ID: 34120602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
